Joe Biden wants diabetes drugs that aid weight loss and treat obesity, such as Wegovy, to fall under Medicare and Medicaid.
Millions more senior citizens and lower-income Americans could obtain coverage for costly anti-obesity drugs under a proposal ...
The Biden administration is looking to expand access to anti-obesity GLP-1 drugs like Ozempic and Wegovy for people who have ...
Medicare and Medicaid recipients with obesity would have access to coverage of pricey GLP-1 receptor agonists like ...
The Biden administration has proposed a new rule to “significantly” expand coverage of anti-obesity medications for Americans ...
U.S. President Joe Biden on Tuesday proposed expanding coverage of anti-obesity drugs, like Novo Nordisk's Wegovy, for more ...
More than seven million additional Americans could get coverage for popular drugs such as Zepbound and Wegovy under the ...
The Biden administration, in one of its last major policy directives, proposed on Tuesday that Medicare and Medicaid cover ...
The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.
Millions of Americans would be eligible to have popular weight-loss drugs like Wegovy or Ozempic covered by Medicare and ...
A new HHS rule would require Medicare and Medicaid to cover drugs like Wegovy or Zepbound for a large segment of Americans.